Skip to main content

Table 4 Baseline characteristics of patient in the treatment failure group vs. the no treatment failure group

From: High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli

Variables Failure
(n = 4)
No failure
(n = 271)
p value*
 %
N % N %
Median age [range] 65.5 [45–87] 57.0 [18–99] 0.37
 Race
  White 3 75.0 101 37.3 0.04
  Black 0 0.0 152 56.1
  Asian 0 0.0 5 1.9
  Other/unknown 1 25.0 13 4.8
 Co-morbidity
  Median Charlson index [range] 0 [0–2] 0 [0–2] 0.19
  Having at least one Charlson conditions 2 50.0 60 22.1 0.22
  Acute myocardial infarction 1 25.0 4 1.5 0.07
  Congestive heart failure 0 0.0 11 4.1 0.99
  Peripheral vascular disease 0 0.0 6 2.2 0.99
  Cerebrovascular disease 2 50.0 12 4.4 0.01
  Dementia 0 0 3 1.1 0.99
  COPD 0 0 15 5.5 0.99
  Rheumatoid disease 0 0 1 0.4 0.99
  Peptic ulcer 0 0 1 0.4 0.99
  Mild liver disease 0 0 1 0.4 0.99
  Moderate/severe liver disease 0 0 0 0
  Diabetes 0 0 4 1.5 0.99
  Hemiplegia or paraplegia 0 0 1 0.4 0.99
  Renal disease 0 0 8 3.0 0.99
  Cancer 0 0 13 4.8 0.99
  Metastatic cancer 0 0 7 2.5 0.99
  AIDS 0 0 0 0
  1. * p value from the non-parametric test